Scandinavian Chemotech // Vetiqure
ChemoTech has extensive experience in the electrochemotherapy treatment method, which forms the basis of the company’s therapeutic areas. Currently, ChemoTech is offering TSE treatment for a variety of cancer tumours and plans to expand operations to advanced electrotherapeutic pain control.
ChemoTech’s first product, IQwave™, improves on the first generation of electrochemotherapy in several ways, among other things; by making it possible to treat hard to reach tumours and using patented technology to minimise the risk of untreated cancer cells. This product is designed according to the market conditions in Asia, the Middle East and Africa.
Scandinavian ChemoTech AB (publ) is a listed company on Nasdaq First North Growth Market Stockholm.